GBLX GB Sciences, Inc.
GB Sciences (GBLX) news
GB Sciences, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker GBLX, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest GB Sciences news
We have not published a story on GB Sciences yet. When there is news, it will appear here.
Questions about GB Sciences
What is the ticker symbol of GB Sciences?
GB Sciences, Inc. trades under the ticker GBLX on OTC.
Where is GB Sciences listed?
GB Sciences, Inc. is listed on OTC.
Which country or territory is GB Sciences listed under?
Our directory records GB Sciences, Inc. under United States.
What does GB Sciences do?
Our directory classifies GB Sciences, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of GB Sciences?
The ISIN recorded for GB Sciences, Inc. is US3615441090.
Does aibio.space cover GB Sciences?
aibio.space lists GB Sciences, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Which companies are similar to GB Sciences?
Companies in our directory listed in the same country and business area as GB Sciences: Seres Therapeutics, Editas Medicine, Fate Therapeutics, MBX Biosciences, Kardigan, Arrowhead Pharmaceuticals.
Investor discussion: GB Sciences
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- GB Sciences, Inc.
- Ticker
- GBLX
- Listing
- OTC
- Country or territory
- United States
- Business scope
- Biotechnology
- ISIN
- US3615441090
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio